Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-04-27Clinical Trial Update: Abraxane and RT for Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating Abraxane with radiation therapy for stage III non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-19Clinical Trial Update: Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC [Phase 1]
A Phase I study evaluating active breathing control with simultaneous boost for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-03-05Clinical Trial Update: Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
The MD Anderson Cancer Center–sponsored Phase 1/Phase 2 trial in non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-02-26Clinical Trial Update: Erlotinib Pharmacokinetics During Doxycycline Treatment for Erlotinib-induced Rash [NA]
A clinical trial assessing Erlotinib pharmacokinetics during doxycycline treatment for Erlotinib-induced rash has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-02-16Clinical Trial Update: NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy [Phase 3]
A Phase 3 trial investigating relapse therapy for non-small cell lung cancer after surgery and perioperative chemotherapy has been terminate…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-01-21Clinical Trial Update: A Study of Ridaforolimus in Non-Small Cell Lung Cancer (NSCLC) Patients With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutations (MK-8669-021 AM1) [Phase 2]
A phase 2 study of ridaforolimus in KRAS-mutant non-small cell lung cancer sponsored by Merck Sharp & Dohme was terminated.
-
CLINICAL_TRIALS withdrawal · 2015-01-12Clinical Trial Update: A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer [Phase 2]
Pfizer-sponsored Phase 2 study for patients with advanced EGFR-mutant non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-12-18Clinical Trial Update: Consolidation Chemotherapy/Concurrent Chemo-radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating consolidation chemotherapy with concurrent chemoradiotherapy for inoperable Stage III non-small cell lung cancer …
-
CLINICAL_TRIALS withdrawal · 2014-11-17Clinical Trial Update: Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 trial combining gp96-Ig vaccine, theophylline, and oxygen for advanced, relapsed or metastatic non-small cell lung cancer has been…
-
CLINICAL_TRIALS withdrawal · 2014-11-13Clinical Trial Update: A Proof of Principle Study of Aminolevulinic Acid (ALA) - Induced Fluorescence Detection in Resectable Non-Small Cell Lung Cancer [Phase 1]
A Phase 1 proof-of-principle trial investigating aminolevulinic acid–induced fluorescence for detecting resectable non-small cell lung cance…
-
CLINICAL_TRIALS withdrawal · 2014-10-29Clinical Trial Update: Celecoxib Treatment for Lung Cancer [Phase 1]
Phase 1 trial of celecoxib for non-small cell lung cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-28Clinical Trial Update: Safety and Tolerability of Trametinib in Combination With Docetaxel in Japanese Subjects With Non-small Cell Lung Cancer [Phase 1]
A Phase 1 trial evaluating the safety and tolerability of trametinib in combination with docetaxel in Japanese patients with non-small cell …
-
CLINICAL_TRIALS withdrawal · 2014-07-24Clinical Trial Update: Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC [Phase 2]
A Phase 2 trial evaluating cabazitaxel for brain metastases arising from breast cancer and non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-07-24Clinical Trial Update: Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507
The update indicates that the laboratory study using samples from patients with non-small cell lung cancer treated on CASE-2507 has been wit…
-
CLINICAL_TRIALS withdrawal · 2014-06-17Clinical Trial Update: Study Of The Effect Of CP-751,871 In Combination With Gemcitabine And Cisplatin In Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
Pfizer withdrew a Phase 3 trial evaluating CP-751,871 in combination with gemcitabine and cisplatin for advanced non-small cell lung cancer.
-
CLINICAL_TRIALS withdrawal · 2014-05-21Clinical Trial Update: Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial evaluating cancer treatment followed by surgery for early-stage non-small cell lung cancer has been withdrawn. The status i…
-
CLINICAL_TRIALS withdrawal · 2014-05-19Clinical Trial Update: A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer [Phase 2]
The Phase 2 trial evaluating Foretinib in non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-03-31Clinical Trial Update: A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
The study evaluating PT-523 in patients with advanced non-small cell lung cancer (Phase 1/2) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-03-04Clinical Trial Update: Efficacy and Safety of a Sunscreen Against Porfimer Sodium-induced Phototoxicity to Visible Light [Phase 2]
A Phase 2 clinical trial evaluating a sunscreen to prevent porfimer sodium–induced phototoxicity to visible light has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-01-29Clinical Trial Update: Hypo-Hyperfractionated Chest Radiation for Non Small Cell Lung Cancer With Taxotere/Xeloda Combination Chemotherapy [Phase 1, Phase 2]
A clinical trial update indicates that the phase 1/2 study evaluating hypo-hyperfractionated chest radiation with Taxotere and Xeloda for no…
-
EMA withdrawal · 2014-01-21EMA Lapsed: Docetaxel Teva Pharma (docetaxel) — Teva Pharma B.V.
The EMA lists Docetaxel Teva Pharma as lapsed (withdrawn) for multiple indications including non-small cell lung carcinoma, breast neoplasms…
-
CLINICAL_TRIALS withdrawal · 2014-01-16Clinical Trial Update: Changes in Brain Structure Related to Systemic Chemotherapy Treatment: A Prospective Study in Individuals Diagnosed With Non-small Cell Lung Cancer Utilizing High-resolution Structural Magnetic Resonance Imaging
The clinical trial investigating brain structure changes in non-small cell lung cancer patients treated with systemic chemotherapy was termi…
-
CLINICAL_TRIALS withdrawal · 2014-01-15Clinical Trial Update: Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer [Phase 1]
A Phase 1 study of photodynamic therapy with temoporfin for non-resectable non-small-cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-12-19Clinical Trial Update: Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation [Phase 1]
A Phase 1 trial of Afatinib in combination with cisplatin or carboplatin plus pemetrexed for EGFR-mutant non-small cell lung cancer undergoi…
-
CLINICAL_TRIALS withdrawal · 2013-12-09Clinical Trial Update: CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial investigating CIK cell transfusion plus adjuvant chemotherapy for stage IB-IIIA non-small cell lung cancer has been withdraw…